grant

Structural studies of viral replication and invasion

Organization UNIVERSITY OF MINNESOTALocation MINNEAPOLIS, UNITED STATESPosted 1 Jul 2016Deadline 31 Dec 2026
NIHUS FederalResearch GrantFY2025AntibodiesAreaCancersCell BodyCellsChromosomesCoV S proteinCoV glycoprotein SCoV spike glycoproteinCoV spike proteinComplexCoronaviridaeCoronavirusCoronavirus glycoprotein SCoronavirus spike proteinDNA TherapyDevelopmentExoribonucleasesGene DeliveryGene Transfer ClinicalGenetic InterventionGenomeGoalsHTLV VirusesHTLV groupHealthHost FactorHost Factor ProteinHumanHuman T-Cell Leukemia VirusesHuman T-Cell Leukemia-Lymphoma VirusesHuman T-lymphotropic VirusesIntegration Host FactorsInvadedLaboratoriesLife CycleLife Cycle StagesMalignant NeoplasmsMalignant TumorModern ManMolecularNon-Polyadenylated RNAOrthocoronavirinaeRNARNA Gene ProductsReceptor InhibitionResearchRetroviridaeRetrovirusesRibonucleic AcidRoleRous sarcoma virusTechniquesViralViral GenomeViral Reverse TranscriptionVirusVirus ReplicationVirus-Retrovirusanti-viral developmentanti-viral drug developmentanti-viral therapeutic developmentanti-viral therapy developmentantiviral developmentantiviral drug developmentantiviral therapeutic developmentantiviral therapy developmentcorona viruscoronavirus S proteincoronavirus spike glycoproteindeveloping anti-viral agentdeveloping anti-viral drugdeveloping anti-viral therapeuticdeveloping anti-viral therapydeveloping antiviral agentdeveloping antiviral drugdeveloping antiviral therapeuticdeveloping antiviral therapydevelopmentalgene repair therapygene therapygene-based therapygenetic therapygenomic therapyhuman pathogeninterestlife coursemalignancyneoplasm/cancernovelreceptor bindingreceptor boundsmall moleculesocial rolestructural biologytoolviral multiplicationviral replicationvirus genomevirus multiplication
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract
Viruses are a major threat to human health. Our laboratory uses various structural biology techniques to

dissect molecular mechanisms of how viruses replicate and invade the host cell or its genome. One area of our

major interest is retroviral integration, a critical step in the lifecycle of retroviruses that achieves permanent

insertion of the reverse-transcribed viral genome into a host chromosome. We will build on our recent structural

studies of the Human T-cell Leukemia virus and Rous sarcoma virus intasomes and further investigate the

roles of host factors during integration of these retroviruses. Another area that we are pursuing is the

replication of coronavirus RNA genomes and host cell invasion. In particular, we are interested in how a virally

encoded exoribonuclease complex facilitates faithful replication of the large RNA genomes of coronaviruses,

and how this unique proofreading activity could be modulated by small molecules. We are also investigating

inhibition of the receptor binding of the coronavirus spike protein by novel antibodies and antibody-mimics.

Overall, the studies proposed in this application will help better understand important RNA-based human

pathogens and could aid in the development of antiviral strategies, or alternatively, gene delivery tools useful in

research or gene therapy applications.

Grant Number: 5R35GM118047-09
NIH Institute/Center: NIH

Principal Investigator: Hideki Aihara

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →